Evidence map›Paper›PMID 42576392›Full record

ArticleAdvanced healthcare materials2026

Patterned ELR-Gelatin Hydrogels Enable Rapid Endothelial Monolayer Formation via Bioactive Matrix Chemistry and Surface Topography.

Jagoda Litowczenko, Yannick Richter, Martyna Michalska, Piotr Paczos, Karine Tadevosyan, Daniel Uribe, Jose Carlos Rodriguez-Cabello, Ioannis Papakonstantinou, Angel Raya

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jagoda LitowczenkoCenter For Advanced Technologies, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego, Poznań, Poland.ORCID https://orcid.org/0000-0002-8515-2171
Yannick RichterStem Cell Potency Group, Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL), L´Hospitalet De Llobregat, Barcelona, Spain.ORCID https://orcid.org/0009-0008-9035-6137
Martyna MichalskaDepartment of Mechanical Engineering, University College London, Torrington Place, London, UK.ORCID https://orcid.org/0000-0003-2910-2767
Piotr PaczosPoznań University of Technology, Poznań, Poland.ORCID https://orcid.org/0000-0001-6054-8834
Karine TadevosyanStem Cell Potency Group, Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL), L´Hospitalet De Llobregat, Barcelona, Spain.ORCID https://orcid.org/0000-0002-6740-0047
Daniel UribeStem Cell Potency Group, Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL), L´Hospitalet De Llobregat, Barcelona, Spain.
Jose Carlos Rodriguez-CabelloCenter For Networked Biomedical Research On Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.ORCID https://orcid.org/0000-0002-3438-858X
Ioannis PapakonstantinouPhotonic Innovations Lab, Department of Electronic & Electrical Engineering, University College London, London, UK.ORCID https://orcid.org/0000-0002-1087-7020
Angel RayaStem Cell Potency Group, Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL), L´Hospitalet De Llobregat, Barcelona, Spain.ORCID https://orcid.org/0000-0003-2189-9775

Funding

ERDFEuropean Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Actions 101025242Fundació La Marató de TV3 202331-30Junta de Castilla y León CLU-2023-1-05Junta de Castilla y León VA188P23National Science Centre, Poland 2022/47/D/ST5/03467Polish Ministry of Science and Higher Education 0612/SBAD/3640Spanish Ministry of Science, Innovation and Universities-MICIU PID2021-123925OB-I00Spanish Ministry of Science, Innovation and Universities-MICIU PID2024-15802908OB-I00
6 · The paper itself

Abstract

The endothelialization of organ-on-chip platforms and vascular implants is often limited by slow cell attachment and unstable monolayer formation. This work presents a scalable workflow that imprints micro- and nano-gratings into elastin-like recombinamer (ELR)-based hydrogels, enabling rapid endothelial cell capture and accelerating monolayer formation within 14 days. Three gelatin-ELR formulations are engineered, with 1H-NMR confirming incorporation of sequences designed to modulate bioactivity (ELR1: inert, ELR2: uPA-responsive, ELR3: RGD-adhesive). ELR incorporation generates fibrillar microstructures and enhances mechanical performance, yielding elastic-dominant networks suitable for high-fidelity pattern transfer. Using this library, the combined effects of ELR bioactivity and groove geometry on human iPSC-derived endothelial cells are evaluated. In a 15-min attachment assay, patterned ELR composites markedly improve cell retention compared to gelatin, with ELR2 on ∼350 and ∼4 µm grooves performing best, consistent with controlled, cell-mediated interfacial remodeling. This early advantage persists, as ELR2 and ELR3 hydrogels support rapid alignment and reach confluence by day 14, whereas gelatin remains subconfluent. By combining enhanced early capture with protease-regulated remodeling, ELR2 identifies a favorable design window. These results establish a materials design framework linking programmable ELR chemistry with surface topography to engineer endothelial interfaces, providing a versatile platform for vascular biomaterials and microphysiological systems.

Indexed as

Endothelial CellsGelatinHydrogelsCell AdhesionElastinSurface PropertiesElastinGelatinHydrogelselastin‐like recombinamersendothelial monolayer formationiPSC‐derived endothelial cellsmicro/nanopatterned hydrogelssoft lithography

Identifiers

PMID42576392
PMCPMC13568830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.